FDA-Drug2026-03-11Class IIPROCESSING DEFECT
Teva Metoprolol Succinate Extended-Release 50 mg tablets recalled for failed dissolution
What this means
Teva Pharmaceuticals is recalling certain batches of Metoprolol Succinate Extended-Release 50 mg tablets because they may not dissolve properly in the body, which could affect how well the medication works. The affected bottles have specific lot numbers and an expiration date of January 2027. No injuries have been reported.
- Check your medication bottle for the lot number and expiration date listed in this recall.
- If your Metoprolol matches the affected lots, contact your pharmacist or doctor for a replacement.
- Do not stop taking your blood pressure medication without talking to your doctor first.
The agency's original wording
Hazard
Failed Dissolution Specifications
Intended for
Adults
Illnesses reported
None reported
Sold states
Nationwide
Affected count
67,043 bottles
Manufactured in
400 Interpace Pkwy Bldg A, N/A, Parsippany, NJ, United States
Products
Metoprolol Succinate Extended-Release Tablets, 50 mg, 100 tablets bottles (NDC: 45963-676-11) and 1,000 tablets bottles (NDC: 45963-676-96), Rx Only, Teva Pharmaceuticals, Parsippany, NJ 07054
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0355-2026More Teva recalls
- FDA-Drug2026-09-09Teva trazodone 50 mg tablets recalled for foreign tablets in bottles
Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.